New grape-derived compounds such as a dihydrocaffeic acid (DHCA) and malvidin-3'-O-glucoside (Mal-gluc) were identified that act as therapeutic agents in treating depression. Scientists from the Icahn School of Medicine at Mount Sinai have published the study online in Nature Communications